FDA
-
-
-
-
-
-
-
Clearmind Medicine doses 20th participant in alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine meets safety endpoint in alcohol disorder trial
-
-
-
-
-
-
-
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine Moving Forward to the Next Stage of Its Clinical Trial Following Data and Safety Monitoring Board Approval
-
-
-
-
-
-
-
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
-
-
-
-
-
-
-
Clearmind Medicine enrolls first patient at Tel Aviv medical center
-
-
-
-
-
-
-
Clearmind Medicine reports positive phase I/IIa trial results for AUD treatment
-
324,382 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

